Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser

February 18, 2022 updated by: Christian Bisp Sørensen, Aalborg University Hospital

This study aims to assess if laser treatment can cure fungal infection in toenails.

Nail clippings from eligible subjects were obtained and randomised into two groups. All nail clippings were treated once with a 1064 nm Nd:YAG-laser. Before and after treatment, nail clippings were tested for fungal infection by microscopy and by culture.

Study Overview

Status

Completed

Detailed Description

This study was carried out as a randomised controlled trial (RCT) including two treatment groups subjected to two different laser treatments. A 1064 nm Nd:YAG-laser (Candela Medical, Ellipse Nordlys (Nd:YAG 1064), USA) was used for all treatments.

Potential subjects were recruited from general practitioners and skin clinics in North Jutland from August 24th, 2021, through December 2021.

All interventions and mycological tests for each subject were performed over the course of one day.

After subjects were included, toenails with a clinical suspicion of onychomycosis (OM) were tested for fungal infection by culture and microscopy. At the same time, nail clippings from said toenails were obtained and randomised into one of two treatment groups, i.e., group A and group B.

The nail clippings were then treated with a 1064 nm Nd:YAG-laser with laser settings as specified by the treatment groups. All nail clippings were treated only once.

Immediately after treatment, nail clippings were again tested for fungal infection by culture and microscopy.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nordjylland
      • Aalborg, Nordjylland, Denmark, 9000
        • Aalborg University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patient (>18 years)
  • Clinical suspicion of fungal infection in at least one toenail
  • Signed informed consent
  • Sufficient nail material to perform two cultures and one nail clipping

Exclusion Criteria:

  • Administration of oral antifungal medication in the last 12 months or topical antifungal medication in the last month
  • Diabetes mellitus with associated peripheral artery disease (PAD) or neuropathy
  • Under the influence of alcohol or illegal narcotics
  • Unable to understand written and spoken Danish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A (Long-pulsed group)
Nail clippings allocated to group A received laser treatment with a 1064 nm Nd:YAG-laser. They received one treatment with laser settings: pulse duration 10 ms, spot size 3 mm, fluence 40-50 J/cm2, number of laser pulses 100 /cm2.

All interventions and mycological tests for each subject were performed over the course of one day.

After subjects were included, toenails with a clinical suspicion of OM were tested for fungal infection by culture and microscopy. At the same time, nail clippings from said toenails were obtained and randomised into one of two treatment groups, i.e., group A and group B.

The nail clippings were then treated with a 1064 nm Nd:YAG-laser with laser settings as specified by the treatment groups. All nail clippings were treated only once.

Immediately after treatment, nail clippings were again tested for fungal infection by culture and microscopy.

Active Comparator: Group B (Short-pulsed group)
Nail clippings allocated to group B received laser treatment with a 1064 nm Nd:YAG-laser. They received one treatment with laser settings: pulse duration 0.3 ms, spot size 3 mm, fluence 40 J/cm2, number of laser pulses 100 /cm2.

All interventions and mycological tests for each subject were performed over the course of one day.

After subjects were included, toenails with a clinical suspicion of OM were tested for fungal infection by culture and microscopy. At the same time, nail clippings from said toenails were obtained and randomised into one of two treatment groups, i.e., group A and group B.

The nail clippings were then treated with a 1064 nm Nd:YAG-laser with laser settings as specified by the treatment groups. All nail clippings were treated only once.

Immediately after treatment, nail clippings were again tested for fungal infection by culture and microscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fungal infection status in nail clippings measured by microscopy after laser treatment.
Time Frame: Approximately 10 minutes after treatment
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by microscopy after therapy.
Approximately 10 minutes after treatment
Fungal infection status in nail clippings measured by culture after laser treatment.
Time Frame: Approximately 10 minutes after treatment
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by culture after therapy.
Approximately 10 minutes after treatment
Fungal infection status in nail clippings measured by microscopy before laser treatment.
Time Frame: Approximately 10 minutes before treatment
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by microscopy before therapy.
Approximately 10 minutes before treatment
Fungal infection status in nail clippings measured by culture before laser treatment.
Time Frame: Approximately 10 minutes before treatment
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by culture before therapy.
Approximately 10 minutes before treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fungal infection status in nail clippings measured by PCR before laser treatment.
Time Frame: Approximately 10 minutes before treatment
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by PCR before therapy.
Approximately 10 minutes before treatment
Fungal infection status in nail clippings measured by PCR after laser treatment.
Time Frame: Approximately 10 minutes after treatment
The number (rate) of included nail clippings in each group that were found negative for fungal infection measured by PCR after therapy.
Approximately 10 minutes after treatment
Nail clippings temperatures
Time Frame: Approximately 2 seconds after end of treatment.
Nail clippings temperature measured at the end of treatment
Approximately 2 seconds after end of treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2021

Primary Completion (Actual)

December 6, 2021

Study Completion (Actual)

December 6, 2021

Study Registration Dates

First Submitted

February 9, 2022

First Submitted That Met QC Criteria

February 18, 2022

First Posted (Actual)

March 2, 2022

Study Record Updates

Last Update Posted (Actual)

March 2, 2022

Last Update Submitted That Met QC Criteria

February 18, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Onychomycosis of Toenail

Clinical Trials on 1064 nm Nd:YAG-laser therapy

Subscribe